skinjectpatch.com
Contact us
About company
SkinJect develops a novel drug delivery system for the treatment of non-melanoma skin cancers. Its system comprises a dissolvable microneedle array (MNA) to deliver a drug directly into the top layer of the skin. The drug will kill non-melanoma skin cancer by causing an immune system reaction to combat the disease. It was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.
US
Unknown
Not verified company
